The effect of paricalcitolon dialysate protein loss in peritoneal dialysis patients

Detalhes bibliográficos
Autor(a) principal: Jerónimo, Teresa
Data de Publicação: 2016
Outros Autores: del Peso, Gloria, Gayo, Lucia, Guedes, A. Malho, Silva, Ana P., Neves, Pedro L., Selgas, Rafael, Bajo, Maria A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.1/9498
Resumo: Ever since peritoneal dialysis (PD) has been used in the treatment of chronic kidney disease (CKD), high peritoneal protein loss has been observed on each PD exchange. In adult patients, the loss has been estimated at 6 to 13 g daily. Paricalcitol, a selective activator of vitamin D receptors (VDR), is successfully used as a treatment of hyperparathyroidism secondary to CKD. In addition, it has been proposed for reducing proteinuria in patients with CKD. Nonetheless, little is known about its effect on peritoneal protein loss (PPL) in patients on PD, namely after the identification of VDRon the peritoneal membrane. The aim of this study wasto examine the effect of paricalcitol on PPL in PD patients.
id RCAP_bb348f9cfd68309724505dedf2bcd66f
oai_identifier_str oai:sapientia.ualg.pt:10400.1/9498
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The effect of paricalcitolon dialysate protein loss in peritoneal dialysis patientsEver since peritoneal dialysis (PD) has been used in the treatment of chronic kidney disease (CKD), high peritoneal protein loss has been observed on each PD exchange. In adult patients, the loss has been estimated at 6 to 13 g daily. Paricalcitol, a selective activator of vitamin D receptors (VDR), is successfully used as a treatment of hyperparathyroidism secondary to CKD. In addition, it has been proposed for reducing proteinuria in patients with CKD. Nonetheless, little is known about its effect on peritoneal protein loss (PPL) in patients on PD, namely after the identification of VDRon the peritoneal membrane. The aim of this study wasto examine the effect of paricalcitol on PPL in PD patients.Oxford University Press (OUP)- European Renal Association - European Dialysis and Transplant Association (ERA-EDTA)SapientiaJerónimo, Teresadel Peso, GloriaGayo, LuciaGuedes, A. MalhoSilva, Ana P.Neves, Pedro L.Selgas, RafaelBajo, Maria A.2017-04-07T15:56:41Z2016-052016-05-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.1/9498eng0931-0509info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-24T10:20:58Zoai:sapientia.ualg.pt:10400.1/9498Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:01:25.835574Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The effect of paricalcitolon dialysate protein loss in peritoneal dialysis patients
title The effect of paricalcitolon dialysate protein loss in peritoneal dialysis patients
spellingShingle The effect of paricalcitolon dialysate protein loss in peritoneal dialysis patients
Jerónimo, Teresa
title_short The effect of paricalcitolon dialysate protein loss in peritoneal dialysis patients
title_full The effect of paricalcitolon dialysate protein loss in peritoneal dialysis patients
title_fullStr The effect of paricalcitolon dialysate protein loss in peritoneal dialysis patients
title_full_unstemmed The effect of paricalcitolon dialysate protein loss in peritoneal dialysis patients
title_sort The effect of paricalcitolon dialysate protein loss in peritoneal dialysis patients
author Jerónimo, Teresa
author_facet Jerónimo, Teresa
del Peso, Gloria
Gayo, Lucia
Guedes, A. Malho
Silva, Ana P.
Neves, Pedro L.
Selgas, Rafael
Bajo, Maria A.
author_role author
author2 del Peso, Gloria
Gayo, Lucia
Guedes, A. Malho
Silva, Ana P.
Neves, Pedro L.
Selgas, Rafael
Bajo, Maria A.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Sapientia
dc.contributor.author.fl_str_mv Jerónimo, Teresa
del Peso, Gloria
Gayo, Lucia
Guedes, A. Malho
Silva, Ana P.
Neves, Pedro L.
Selgas, Rafael
Bajo, Maria A.
description Ever since peritoneal dialysis (PD) has been used in the treatment of chronic kidney disease (CKD), high peritoneal protein loss has been observed on each PD exchange. In adult patients, the loss has been estimated at 6 to 13 g daily. Paricalcitol, a selective activator of vitamin D receptors (VDR), is successfully used as a treatment of hyperparathyroidism secondary to CKD. In addition, it has been proposed for reducing proteinuria in patients with CKD. Nonetheless, little is known about its effect on peritoneal protein loss (PPL) in patients on PD, namely after the identification of VDRon the peritoneal membrane. The aim of this study wasto examine the effect of paricalcitol on PPL in PD patients.
publishDate 2016
dc.date.none.fl_str_mv 2016-05
2016-05-01T00:00:00Z
2017-04-07T15:56:41Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.1/9498
url http://hdl.handle.net/10400.1/9498
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0931-0509
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Oxford University Press (OUP)- European Renal Association - European Dialysis and Transplant Association (ERA-EDTA)
publisher.none.fl_str_mv Oxford University Press (OUP)- European Renal Association - European Dialysis and Transplant Association (ERA-EDTA)
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133243896758272

Registros relacionados